The Ministry of Health and Family Welfare (MoHFW) on August 06, 2026, notified Stricter Drugs Rules to Debar Applicants Submitting Fake or Fabricated Data.
The Ministry of Health & Family Welfare has amended the Drugs Rules, 1945 (via G.S.R. 756(E), dated October 16, 2025) to strengthen transparency and integrity in India’s drug regulatory system. The amendment empowers licensing authorities to debar applicants who submit fake or fabricated data from filing future applications for a specified period, in addition to existing actions like rejection or cancellation of licenses. A due process mechanism, including show-cause notice and appeal provisions, has been established before imposing such penalties.
This move aims to ensure that drug approvals are based on reliable scientific evidence, thereby safeguarding drug quality, safety, and public health. It also aligns with global regulatory standards and promotes ethical practices in the pharmaceutical sector by discouraging malpractice and holding non-compliant entities accountable.
https://egazette.gov.in/WriteReadData/2026/275233.pdf
[Release ID: 2295399]
